177
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Interaction of methamphetamine abuse, tobacco abuse, and gender in the brain

, PhD

References

  • Sung Y-H, Yurgelun-Todd D, Kondo, D, Shi X, Lundberg K, Hellem T, Huber R, et al. Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine dependent subjects. Am J Alcohol Drug Abuse 2015;41:281–289
  • Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, et al. Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Depend 2013;129:102–109
  • Lee PN. Smoking and Alzheimer’s disease: a review of the epidemiological evidence. Neuroepidemiology 1994;13:131–144
  • Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732–738
  • Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidem 1996;144:400–404
  • Wirdefeldt K, Adami H-O, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidem 2011;26:S1–S58
  • Durazzo TC, Mattson N, Weiner MW. Alzheimer’s disease neuroimaging initiative. Alzheimer’s Dementia 2014;10:S122–S145
  • Weinberger AH, Sofuoglu M. The impact of cigarette smoking on stimulant addiction. Am J Drug Alcohol Abuse 2009;35:12–17
  • Yen CF, Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry 2006;47:215–220
  • Vogt BA. Regions and subregions of the cingulate gyrus. In: Vogt BA, ed. Cingulate neurobiology and disease. New York: Oxford University Press; 2009:3–30
  • Konarski JZ, Kenendy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 2009;34:175–180
  • Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057–1061

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.